Your browser doesn't support javascript.
loading
Impact of Fontan Fenestration on Adverse Cardiovascular Outcomes: A Multicentre Study.
Dib, Nabil; Samuel, Michelle; Levesque, Sylvie; Zaidi, Ali; Cohen, Sarah; Opotowsky, Alexander R; Mongeon, François-Pierre; Mondésert, Blandine; Kay, Joseph; Ibrahim, Reda; Hamilton, Robert M; Fournier, Anne; Jameson, Susan M; Dore, Annie; Cook, Stephen C; Cohen, Scott; Chaix, Marie-A; Broberg, Craig S; Aboulhosn, Jamil; Poirier, Nancy; Khairy, Paul.
Afiliação
  • Dib N; Montreal Heart Institute, Université de Montréal, Montréal, Québec, Canada.
  • Samuel M; Montreal Heart Institute, Université de Montréal, Montréal, Québec, Canada.
  • Levesque S; Montreal Health Innovations Coordinating Center, Montréal, Québec, Canada.
  • Zaidi A; Nationwide Children's Hospital, Ohio State University, Columbus, Ohio, USA.
  • Cohen S; Hôpital Marie-Lannelongue, Groupe Hospitalier Saint-Joseph, Le Plessis Robinson, Paris, France.
  • Opotowsky AR; Boston Adult Congenital Heart Service, Boston Children's Hospital and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; The Cincinnati Adult Congenital Heart Disease Program, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.
  • Mongeon FP; Montreal Heart Institute, Université de Montréal, Montréal, Québec, Canada.
  • Mondésert B; Montreal Heart Institute, Université de Montréal, Montréal, Québec, Canada.
  • Kay J; University of Colorado Denver, Aurora, Colorado, USA.
  • Ibrahim R; Montreal Heart Institute, Université de Montréal, Montréal, Québec, Canada.
  • Hamilton RM; The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Fournier A; Hôpital Sainte-Justine, Université de Montréal, Montréal, Québec, Canada.
  • Jameson SM; Stanford Adult Congenital Heart Program, Lucile Packard Children's Hospital Stanford and Stanford Health Care, Stanford University School of Medicine, Palo Alto, California, USA.
  • Dore A; Montreal Heart Institute, Université de Montréal, Montréal, Québec, Canada.
  • Cook SC; Indiana University Health Medical Center, Indianapolis, Indiana, USA.
  • Cohen S; The Wisconsin Adult Congenital Heart (WAtCH) Program, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Chaix MA; Montreal Heart Institute, Université de Montréal, Montréal, Québec, Canada.
  • Broberg CS; Oregon Health and Science University, Portland, Oregon, USA.
  • Aboulhosn J; Ahmanson/UCLA Adult Congenital Heart Program, University of California, Los Angeles, California, USA.
  • Poirier N; Montreal Heart Institute, Université de Montréal, Montréal, Québec, Canada.
  • Khairy P; Montreal Heart Institute, Université de Montréal, Montréal, Québec, Canada. Electronic address: paul.khairy@umontreal.ca.
Can J Cardiol ; 2024 Feb 01.
Article em En | MEDLINE | ID: mdl-38309467
ABSTRACT

BACKGROUND:

Fenestrating a Fontan baffle has been associated with improved perioperative outcomes in patients with univentricular hearts. However, longer-term potential adverse effects remain debated. We sought to assess the impact of a fenestrated Fontan baffle on adverse cardiovascular events including all-cause mortality, cardiac transplantation, atrial arrhythmias, and thromboemboli.

METHODS:

A multicentre North American retrospective cohort study was conducted on patients with total cavopulmonary connection Fontan baffle, with and without fenestration. All components of the composite outcome were independently adjudicated. Potential static and time-varying confounders were taken into consideration, along with competing risks.

RESULTS:

A total of 407 patients were followed for 10.4 (7.1-14.4) years; 70.0% had fenestration of their Fontan baffle. The fenestration spontaneously closed or was deliberately sealed in 79.9% of patients a median of 2.0 years after Fontan completion. In multivariable analysis in which a persistent fenestration was modelled as a time-dependent variable, an open fenestration did not confer a higher risk of the composite outcome (hazard ratio, 1.18; 95% confidence interval, 0.71-1.97; P = 0.521). In secondary analyses, an open fenestration was not significantly associated with components of the primary

outcome:

that is, mortality or transplantation, atrial arrhythmias, or thromboemboli. However, sensitivity analyses to assess the possible range of error resulting from imprecise dates for spontaneous fenestration closures could not rule out significant associations between an open fenestration and atrial arrhythmias or thromboemboli.

CONCLUSIONS:

In this multicentre study, no significant association was identified between an open fenestration in the Fontan baffle and major adverse cardiovascular events.

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Can J Cardiol Assunto da revista: CARDIOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Can J Cardiol Assunto da revista: CARDIOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá